dr. plimack on choosing a checkpoint inhibitor in bladder cancer
Published 6 years ago • 82 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
0:55
dr. plimack on frontline checkpoint inhibitors in bladder cancer
-
1:14
dr. plimack on second-line checkpoint inhibitors in bladder cancer
-
1:04
dr. plimack on immunotherapy combinations in bladder cancer
-
0:51
dr. elizabeth plimack on ipilimumab and pd-l1 inhibitors in the treatment of bladder cancer
-
0:47
dr. plimack on the challenges with available immunotherapies for bladder cancer
-
17:44
immune checkpoint inhibitors in lymphoma
-
44:56
immune checkpoint blockade in cancer therapy
-
12:46
clinical trials for ctcl and how to find them
-
1:18
dr. plimack on combo of pembrolizumab/epacodostat in bladder cancer
-
1:06
dr. o'donnell compares checkpoint inhibitors in bladder cancer
-
1:00
dr. plimack on the growth of immunotherapy in bladder cancer
-
0:49
dr. elizabeth plimack on immunotherapy potential in bladder cancer
-
0:56
dr. petrylak on ongoing investigations of checkpoint inhibition in bladder cancer
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
1:00
dr. apolo on toxicity challenges with checkpoint inhibitors in bladder cancer
-
5:14
treatment of bladder cancer-immune checkpoint inhibitors
-
6:00
use of immune checkpoint inhibitors for bladder cancer
-
1:51
dr. grivas on checkpoint inhibitors in localized bladder cancer
-
4:27
check point inhibition in muscle-invasive bladder cancer
-
1:28
dr. flaig on immune checkpoint inhibitors in advanced bladder cancer
-
1:09
dr. plimack on frontline pembrolizumab for urothelial carcinoma
-
1:32
dr. apolo on managing toxicities of checkpoint inhibitors in bladder cancer